Intermediate monocytes contribute to pathologic immune response in leishmania braziliensis infections

Journal of Infectious Diseases

Volumn 211, Issue 2, 2015, Pages 274-282

  Passos, Sara ^a,b   Carvalho, Lucas P ^a,b   Costa, Rubia S ^a   Campos, Taís M ^a   Novais, Fernanda O ^c   Magalhães, Andréa ^a   Machado, Paulo R L ^a,b   Beiting, Daniel ^c   Mosser, David ^d   Carvalho, Edgar M ^a,b   Scott, Phillip ^c  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b Instituto Nacional de Ciencia e Tecnologia de Doencas Tropicais   (Brazil)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Bldg 142   (United States)

Author keywords

immune response; L. braziliensis; monocytes

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CHEMOKINE RECEPTOR CCR2; TUMOR NECROSIS FACTOR; CCL2 PROTEIN, HUMAN; CCR2 PROTEIN, HUMAN; FC RECEPTOR; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEISHMANIA BRAZILIENSIS; MALE; MONOCYTE; PARASITE MIGRATION; PROTEIN EXPRESSION; SKIN LEISHMANIASIS; SKIN ULCER; ADOLESCENT; CHEMISTRY; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; SECRETION (PROCESS); ULCER; YOUNG ADULT;

ADOLESCENT; ADULT; CHEMOKINE CCL2; FEMALE; GPI-LINKED PROTEINS; HUMANS; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; MONOCYTES; RECEPTORS, CCR2; RECEPTORS, IGG; TUMOR NECROSIS FACTOR-ALPHA; ULCER; YOUNG ADULT;

EID: 84922513710     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu439     Document Type: Article

References (46)

1. Carvalho LP, Passos S, Schriefer A, Carvalho EM. Protective and pathologic immune responses in human tegumentary leishmaniasis. Front Immunol 2012; 3:301.
2. Santos Cda S, Boaventura V, Ribeiro Cardoso C, et al. CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNgamma(+)-mediated parasite killing in human cutaneous leishmaniasis. J Invest Dermatol 2013; 133:1533-40.
3. Zaph C, Uzonna J, Beverley SM, Scott P. Central memory T cells mediate long-Term immunity to Leishmania major in the absence of persistent parasites. Nat Med 2004; 10:1104-10.
4. Keesen TS, Antonelli LR, Faria DR, et al. CD4(+) T cells defined by their Vbeta T cell receptor expression are associated with immunoregulatory profiles and lesion size in human leishmaniasis. Clin Exp Immunol 2011; 165:338-51.
5. Anderson CF, Stumhofer JS, Hunter CA, Sacks D. IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection. J Immunol 2009; 183:4619-27.
6. Novais FO, Carvalho LP, Graff JW, et al. Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis. PLoS Pathog 2013; 9:e1003504.
7. Leon B, Lopez-Bravo M, Ardavin C. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 2007; 26:519-31.
8. Novais FO, Nguyen BT, Beiting DP, et al. Human classical monocytes control the intracellular stage of Leishmania braziliensis by reactive oxygen species. J Infect Dis 2014; 209:1288-96.
9. Zawada AM, Rogacev KS, Rotter B, et al. SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood 2011; 118:e50-61.
10. Ziegler-Heitbrock L, Ancuta P, Crowe S, et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010; 116:e74-80.
11. Wong KL, Tai JJ, Wong WC, et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 118:e16-31.
12. Ansari AW, Meyer-Olson D, Schmidt RE. Selective expansion of proinflammatory chemokine CCL2-loaded CD14+CD16+ monocytes subset in HIV-infected therapy naive individuals. J Clin Immunol 2012; 33: 302-6.
13. Belge KU, Dayyani F, Horelt A, et al. The proinflammatory CD14+ CD16+DR++ monocytes are a major source of TNF. J Immunol 2002; 168:3536-42.
14. Ziegler-Heitbrock HW, Fingerle G, Strobel M, et al. The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages. Eur J Immunol 1993; 23:2053-8.
15. Passlick B, Flieger D, Ziegler-Heitbrock HW. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989; 74:2527-34.
16. Fingerle G, Pforte A, Passlick B, Blumenstein M, Strobel M, Ziegler-Heitbrock HW. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 1993; 82:3170-6.
17. Kawanaka N, Yamamura M, Aita T, et al. CD14+, CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum 2002; 46:2578-86.
18. Soares G, Barral A, Costa JM, Barral-Netto M, Van Weyenbergh J. CD16+ monocytes in human cutaneous leishmaniasis: increased ex vivo levels and correlation with clinical data. J Leukoc Biol 2006; 79:36-9.
19. Barral A, Barral-Netto M, Almeida R, et al. Lymphadenopathy associated with Leishmania braziliensis cutaneous infection. Am J Trop Med Hyg 1992; 47:587-92.
20. Barral A, Guerreiro J, Bomfim G, Correia D, Barral-Netto M, Carvalho EM. Lymphadenopathy as the first sign of human cutaneous infection by Leishmania braziliensis. Am J Trop Med Hyg 1995; 53:256-9.
21. Bittencourt AL, Barral A. Evaluation of the histopathological classifications of American cutaneous and mucocutaneous leishmaniasis. Mem Inst Oswaldo Cruz 1991; 86:51-6.
22. Voronov E, Dotan S, Gayvoronsky L, et al. IL-1-induced inflammation promotes development of leishmaniasis in susceptible BALB/c mice. Int Immunol 2010; 22:245-57.
23. Gonzalez-Lombana C, Gimblet C, Bacellar O, et al. IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection. PLoS Pathog 2011; 9:e1003243.
24. Antonelli LR, DutraWO, Almeida RP, Bacellar O, Carvalho EM, Gollob KJ. Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis. Immunol Lett 2005; 101:226-30.
25. Faria DR, Gollob KJ, Barbosa J Jr, et al. Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect Immun 2005; 73:7853-9.
26. Bafica A, Oliveira F, Freitas LA, Nascimento EG, Barral A. American cutaneous leishmaniasis unresponsive to antimonial drugs: successful treatment using combination of N-methilglucamine antimoniate plus pentoxifylline. Int J Dermatol 2003; 42:203-7.
27. Sadeghian G, Nilforoushzadeh MA. Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis. Int J Dermatol 2006; 45:819-21.
28. Ribeiro De Jesus A, Luna T, Pacheco De Almeida R, Machado PR, Carvalho EM. Pentoxifylline down modulate in vitro T cell responses and attenuate pathology in Leishmania and HTLV-I infections. Int Immunopharmacol 2008; 8:1344-53.
29. Bacellar O, Lessa H, Schriefer A, et al. Up-regulation of Th1-Type responses in mucosal leishmaniasis patients. Infect Immun 2002; 70:6734-40.
30. Carvalho LP, Passos S, Bacellar O, et al. Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis. Parasite Immunol 2007; 29:251-8.
31. Ribeiro-de-Jesus A, Almeida RP, Lessa H, Bacellar O, Carvalho EM. Cytokine profile and pathology in human leishmaniasis. Braz J Med Biol Res 1998; 31:143-8.
32. Giudice A, Vendrame C, Bezerra C, et al. Macrophages participate in host protection and the disease pathology associated with Leishmania braziliensis infection. BMC Infect Dis 2012; 12:75.
33. Grage-Griebenow E, Flad HD, Ernst M. Heterogeneity of human peripheral blood monocyte subsets. J Leukoc Biol 2001; 69:11-20.
34. Randolph GJ, Sanchez-Schmitz G, Liebman RM, Schakel K. The CD16 (+) (FcgammaRIII(+)) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J Exp Med 2002; 196:517-27.
35. Conrad SM, Strauss-Ayali D, Field AE, Mack M, Mosser DM. Leishmania-derived murine monocyte chemoattractant protein 1 enhances the recruitment of a restrictive population of CC chemokine receptor 2-positive macrophages. Infect Immun 2007; 75:653-65.
36. Quinones MP, Estrada CA, Jimenez F, et al. CCL2-independent role of CCR2 in immune responses against Leishmania major. Parasite Immunol 2007; 29:211-7.
37. Bjorkander S, Heidari-Hamedani G, Bremme K, Gunnarsson I, Holmlund U. Peripheral monocyte expression of the chemokine receptors CCR2, CCR5 and CXCR3 is altered at parturition in healthy women and in women with systemic lupus erythematosus. Scand J Immunol 2013; 77:200-12.
38. Melby PC, Andrade-Narvaez FJ, Darnell BJ, Valencia-Pacheco G, Tryon VV, Palomo-Cetina A. Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis. Infect Immun 1994; 62:837-42.
39. Oliveira F, Bafica A, Rosato AB, et al. Lesion size correlates with Leishmania antigen-stimulated TNF-levels in human cutaneous leishmaniasis. Am J Trop Med Hyg 2011; 85:70-3.
40. Carvalho LP, Petritus PM, Trochtenberg AL, et al. Lymph node hypertrophy following Leishmania major infection is dependent on TLR9. J Immunol 2011; 188:1394-401.
41. Goncalves R, Zhang X, Cohen H, Debrabant A, Mosser DM. Platelet activation attracts a subpopulation of effector monocytes to sites of Leishmania major infection. J Exp Med 2011; 208:1253-65.
42. Kavoosi G, Ardestani SK, Kariminia A. The involvement of TLR2 in cytokine and reactive oxygen species (ROS) production by PBMCs in response to Leishmania major phosphoglycans (PGs). Parasitology 2009; 136:1193-9.
43. Dimitrov S, Shaikh F, Pruitt C, et al. Differential TNF production by monocyte subsets under physical stress: blunted mobilization of proinflammatory monocytes in prehypertensive individuals. Brain Behav Immun 2012; 27:101-8.
44. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007; 81:584-92.
45. FrankenbergerM, Sternsdorf T, Pechumer H, Pforte A, Ziegler-Heitbrock HW. Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis. Blood 1996; 87:373-7.
46. Chakrabarti S, Zee JM, Patel KD. Regulation of matrix metalloproteinase-9 (MMP-9) in TNF-stimulated neutrophils: novel pathways for tertiary granule release. J Leukoc Biol 2006; 79:214-22.